Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Onco-Boost
Therapeutic Area : Oncology
Study Phase : IND Enabling
Sponsor : Xista Science Ventures
Deal Size : $2.1 million
Deal Type : Financing
HEPHAISTOS-Pharma Raises €2 Million Seed Round with Xista Science Ventures and Others
Details : The proceeds will enable HEPHAISTOS to advance ONCO-Boost into clinical development for solid tumors, focusing on unmet needs like sarcoma.
Product Name : Onco-Boost
Product Type : Undisclosed
Upfront Cash : Undisclosed
January 23, 2024
Lead Product(s) : Onco-Boost
Therapeutic Area : Oncology
Highest Development Status : IND Enabling
Sponsor : Xista Science Ventures
Deal Size : $2.1 million
Deal Type : Financing